Who To Contact
Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207
Poonam K. Neki, MBBS,DA, CCRP
Research Director
Baptist MD Anderson Clinical Trials
904.202.7468
poonam.neki@bmcjax.com
Clinical Trial ID: NCT03222609
A Phase 2 Open-Label Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination with Ruxolitinib in Subjects with Myelofibrosis
Status
Open
Conditions
Bones and Joints
Phases
II (Cancer Control)
Age Group
Adult
Main Investiagtor
Norkin, Maxim
Practice
Bone Marrow
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center
Nct ID Number
NCT03222609
Secondary Trial ID Number
M16-109/AbbVie
Keywords
Treatment